Evaluation of action mechanisms of toxic chemicals using JFCR39, a panel of human cancer cell lines

Molecular Pharmacology

Volumn 72, Issue 5, 2007, Pages 1171-1180

  Nakatsu, Noriyuki ^a,b   Nakamura, Tomoki ^a,c   Yamazaki, Kanami ^a   Sadahiro, Soutaro ^c   Makuuchi, Hiroyasu ^c   Kanno, Jun ^b   Yamori, Takao ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBOPLATIN; CARMOFUR; CHLORMETHINE; CISPLATIN; COLCHICINE; CYCLOHEXIMIDE; CYTARABINE; DIGOXIN; DOCETAXEL; FLUOROURACIL; HYDROQUINONE; IRINOTECAN; METHOTREXATE; MITOMYCIN; OKADAIC ACID; PACLITAXEL; PARAQUAT; RETINOIC ACID; TAMOXIFEN; TEGAFUR; THALIDOMIDE; THIRAM; TOREMIFENE; TRIAZINE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIRAM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL;

CELL LINE, TUMOR; CLUSTER ANALYSIS; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; HUMANS; PHARMACOLOGY; TISSUE ARRAY ANALYSIS;

EID: 35548960145     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.038836     Document Type: Article

References (26)

1. Akashi T, Nishimura Y, Wakatabe R, Shiwa M, and Yamori T (2007) Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer. Biochem Biophys Res Commun 352:514-521.
2. Akashi T and Yamori T (2007) A novel method for analyzing phosphoproteins using SELDI-TOF MS in combination with a series of recombinant proteins. Proteomics 7:2350-2354
3. Aström A, Pettersson U, Krust A, Chambon P, and Voorhees JJ (1990) Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochem Biophys Res Commun 173:339-345.
4. Cereser C, Boget S, Parvaz P, and Revol A (2001) An evaluation of thiram toxicity on cultured human skin fibroblasts. Toxicology 162:89-101.
5. Chválová K, Brabec V, and Kasparkova J (2007) Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res 35:1812-1821.
6. Dan S, Shirakawa M, Mukai Y, Yoshida Y, Yamazaki K, Kawaguchi T, Matsuura M, Nakamura Y, and Yamori T (2003) Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines. Cancer Sci 94:1074-1082.
7. Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, Yamazaki K, Nakamura Y, and Yamori T (2002) An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res 62:1139-1147.
8. Hershberger LG, Shipley EG, and Meyer RK (1953) Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med 83:175-180.
9. Jamieson ER and Lippard SJ (1999) Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev 99:2467-2498.
10. Kanno J, Kato H, Iwata T, and Inoue T (2002) Phytoestrogen-low diet for endocrine disruptor studies. J Agric Food Chem 50:3883-3885.
11. Naasani I, Seimiya H, Yamori T, and Tsuruo T (1999) FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res 59:4004-4011.
12. Nakamura H, Dan S, Akashi T, Unno M, and Yamori T (2007) Absolute quantification of four isoforms of the class I phosphoinositide-3-kinase catalytic subunit by real-time RT-PCR. Biol Pharm Bull 30:1181-1184.
13. Nakatsu N, Yoshida Y, Yamazaki K, Nakamura T, Dan S, Fukui Y, and Yamori T (2005) Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays. Mol Cancer Ther 4:399-412.
14. Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H, Yanagawa R, Miyawaki S, Kuriyama K, Kubota N, et al. (2002) Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis. Mol Cancer Ther 1:1035-1042.
15. Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, Plowman J, and Boyd MR (1989) Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst 81:1088-1092.
16. 2+ exchanger is essential for the action of cardiac glycosides. Circ Res 90:305-308.
17. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24:236-244.
18. Suntres ZE (2002) Role of antioxidants in paraquat toxicity. Toxicology 180:65-77.
19. Weinstein JN, Kohn KW, Grever MR, Viswanadhan VN, Rubinstein LV, Monks AP, Scudiero DA, Welch L, Koutsoukos AD, and Chiausa AJ (1992) Neural computing in cancer drug development: predicting mechanism of action. Science 258:447-451.
20. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, et al. (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349.
21. Wong E and Giandomenico CM (1999) Current status of platinum-based antitumor drugs. Chem Rev 99:2451-2466.
22. Yaguchi S, Fukui Y, Koshimizu I, Matsuno T, Gouda H, Hirono S, Yamazaki K, and Yamori T (2006) Antitumor activity of ZSTK474, a new phosphatidyl inositol 3-kinase inhibitor. J Natl Cancer Inst 98:545-556.
23. Yamori T (2003) Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics. Cancer Chemother Pharmacol 52 (Suppl 1): S74-S79
24. Yamori T, Matsunaga A, Sato S, Yamazaki K, Komi A, Ishizu K, Mita I, Edatsugi H, Matsuba Y, Takezawa K, et al. (1999) Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res 59:4042-4049,.
25. Zembutsu H, Ohnishi Y, Tsunoda T, Furukawa Y, Katagiri T, Ueyama Y, Tamaoki N, Nomura T, Kitahara O, Yanagawa R, et al. (2002) Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res 62:518-527.
26. Zwelling LA, Anderson T, and Kohn KW (1979) DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res 39:365-369.